Clinical trial
US Inhaled Insulin Dose Titration Study
NCT00246623 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00246623 |
|---|---|
| Title | US Inhaled Insulin Dose Titration Study |
| Official title | A Randomized, Open-Label, Multicenter Study Assessing the Effects of Forced Exubera Dose Titration on Glycemic Control in Patients With Suboptimally Controlled Type 2 Diabetes on Two or More Oral Antidiabetic Agents |
| Lead sponsor | Pfizer, Industry |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Behavioral, Drug, Procedure |
| Interventions | Exubera (inhaled insulin), 8-point glucose diary (to assess pre- and post prandial glucoses), Meal Tolerance Test, 24-hour continuous glucose monitoring (at select sites), Pulmonary Function Testing, Hypoglycemic Event Monitoring, Laboratory Assessments, Nutritional Counseling and Diabetes Education |
| Enrollment | 120 |
| Start date | Nov 1, 2005 |
| Completion | Mar 1, 2007 |
| First posted | Oct 31, 2005 |
| Last update posted | Feb 8, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: